ARQT
Price
$13.02
Change
-$0.40 (-2.98%)
Updated
Feb 21 closing price
Capitalization
1.52B
2 days until earnings call
BPMC
Price
$92.25
Change
-$2.10 (-2.23%)
Updated
Feb 21 closing price
Capitalization
5.9B
67 days until earnings call
Ad is loading...

ARQT vs BPMC

Header iconARQT vs BPMC Comparison
Open Charts ARQT vs BPMCBanner chart's image
Arcutis Biotherapeutics
Price$13.02
Change-$0.40 (-2.98%)
Volume$1.89M
Capitalization1.52B
Blueprint Medicines
Price$92.25
Change-$2.10 (-2.23%)
Volume$876.27K
Capitalization5.9B
ARQT vs BPMC Comparison Chart
Loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARQT vs. BPMC commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a Hold and BPMC is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ARQT: $13.02 vs. BPMC: $92.25)
Brand notoriety: ARQT and BPMC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 87% vs. BPMC: 92%
Market capitalization -- ARQT: $1.52B vs. BPMC: $5.9B
ARQT [@Biotechnology] is valued at $1.52B. BPMC’s [@Biotechnology] market capitalization is $5.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 0 FA rating(s) are green whileBPMC’s FA Score has 0 green FA rating(s).

  • ARQT’s FA Score: 0 green, 5 red.
  • BPMC’s FA Score: 0 green, 5 red.
According to our system of comparison, ARQT is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 5 TA indicator(s) are bullish while BPMC’s TA Score has 6 bullish TA indicator(s).

  • ARQT’s TA Score: 5 bullish, 5 bearish.
  • BPMC’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, BPMC is a better buy in the short-term than ARQT.

Price Growth

ARQT (@Biotechnology) experienced а +1.88% price change this week, while BPMC (@Biotechnology) price change was -1.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ARQT is expected to report earnings on May 20, 2025.

BPMC is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.9B) has a higher market cap than ARQT($1.52B). BPMC YTD gains are higher at: 5.767 vs. ARQT (-6.533). BPMC has higher annual earnings (EBITDA): -75.58M vs. ARQT (-163.28M). BPMC has more cash in the bank: 734M vs. ARQT (331M). ARQT has less debt than BPMC: ARQT (208M) vs BPMC (471M). BPMC has higher revenues than ARQT: BPMC (434M) vs ARQT (139M).
ARQTBPMCARQT / BPMC
Capitalization1.52B5.9B26%
EBITDA-163.28M-75.58M216%
Gain YTD-6.5335.767-113%
P/E RatioN/AN/A-
Revenue139M434M32%
Total Cash331M734M45%
Total Debt208M471M44%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARQTBPMC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
ARQT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KGRN26.630.90
+3.50%
KraneShares MSCI China Clean Tech ETF
WTMF34.75-0.32
-0.91%
WisdomTree Managed Futures Strategy ETF
EWY57.59-0.87
-1.49%
iShares MSCI South Korea ETF
USSG54.44-1.09
-1.96%
Xtrackers MSCI USA Selection Eq ETF
BPAY26.74-1.63
-5.74%
iShares FinTech Active ETF

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with BEAM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
-2.98%
BEAM - ARQT
38%
Loosely correlated
-8.18%
TRDA - ARQT
37%
Loosely correlated
-0.23%
BPMC - ARQT
35%
Loosely correlated
-2.23%
PRTA - ARQT
35%
Loosely correlated
+2.03%
XENE - ARQT
34%
Loosely correlated
+0.89%
More

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with DNLI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
-2.23%
DNLI - BPMC
43%
Loosely correlated
-3.98%
AXON - BPMC
41%
Loosely correlated
-5.28%
ORIC - BPMC
41%
Loosely correlated
+2.81%
TECH - BPMC
39%
Loosely correlated
-0.87%
VCYT - BPMC
39%
Loosely correlated
-4.56%
More